HomeCompareMICDX vs KMB

MICDX vs KMB: Dividend Comparison 2026

MICDX yields 3.94% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MICDX wins by $1657.81M in total portfolio value
10 years
MICDX
MICDX
● Live price
3.94%
Share price
$15.51
Annual div
$0.61
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1657.86M
Annual income
$1,580,697,529.21
Full MICDX calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — MICDX vs KMB

📍 MICDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMICDXKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MICDX + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MICDX pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MICDX
Annual income on $10K today (after 15% tax)
$334.51/yr
After 10yr DRIP, annual income (after tax)
$1,343,592,899.83/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, MICDX beats the other by $1,343,588,460.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MICDX + KMB for your $10,000?

MICDX: 50%KMB: 50%
100% KMB50/50100% MICDX
Portfolio after 10yr
$828.95M
Annual income
$790,351,375.78/yr
Blended yield
95.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

MICDX
No analyst data
Altman Z
-0.7
Piotroski
4/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MICDX buys
0
KMB buys
0
No recent congressional trades found for MICDX or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMICDXKMB
Forward yield3.94%5.25%
Annual dividend / share$0.61$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%17%
Portfolio after 10y$1657.86M$45.9K
Annual income after 10y$1,580,697,529.21$5,222.34
Total dividends collected$1652.33M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MICDX vs KMB ($10,000, DRIP)

YearMICDX PortfolioMICDX Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$11,487$787.08$11,314$614.45+$173.00MICDX
2$13,981$1,689.95$12,867$760.19+$1.1KMICDX
3$18,804$3,844.62$14,713$945.27+$4.1KMICDX
4$29,786$9,665.34$16,924$1,181.90+$12.9KMICDX
5$60,488$28,616.51$19,596$1,486.64+$40.9KMICDX
6$173,343$108,621.54$22,850$1,882.16+$150.5KMICDX
7$767,316$581,838.97$26,849$2,399.80+$740.5KMICDX
8$5,635,143$4,814,114.67$31,812$3,083.36+$5.60MMICDX
9$72,113,126$66,083,522.55$38,033$3,994.72+$72.08MMICDX
10$1,657,858,574$1,580,697,529.21$45,918$5,222.34+$1657.81MMICDX

MICDX vs KMB: Complete Analysis 2026

MICDXStock

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in dividend-paying equity securities of companies located in China. It may also invest in convertible debt and equity securities of any maturity and quality, including those that are unrated, or would be below investment grade if rated, of companies located in China. China also includes its administrative and other districts, such as Hong Kong.

Full MICDX Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this MICDX vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MICDX vs SCHDMICDX vs JEPIMICDX vs OMICDX vs KOMICDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.